was mainly due to an improve on the inventory cost management continued from year 2017 as well as sales mix management in each product category efficiently. However, the Company still strictly
power was limited following rising energy price and inflation. The increased cost of living put pressure on consumers to spend wisely and reduced costs where required. The economic recovery benefited
in order to maintain liquidity and financial flexibility. The Company remains cautious on investment, while seeking various sources of working capital, along with effective control and management of
and finance cost. In the first half of 2020, the Company had total consolidated expenses of 9,199 million baht, an increase of 535 million baht or 6% y-y. For the second quarter of 2020, the
Reporting Standards No.9, (“TFRS 9”), on the allowance for doubtful accounts. Finance Cost Q2/2020, the Company and its subsidiaries had the financial cost of 0.8 MB which decreased from Q2/2019 in the
Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the 3rd quarter of 2018 ending September 30, 2018 which has been
. However, the Company still maintained effective operating cost control with cost to income ratio at 38% of total revenues. Considering the Company’s separate financial statement, the operating and
of intangible asset from the acquisition of GLOW 2. From the second quarter of 2019, the company has changed the classification of operating income and cost of sales resultin g in the operating income